Project Grant R01GM166117
Award Date 9/1/26
Completion Date 4/30/31
Dollars Obligated $359K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
- The National Institute of General Medical Sciences awarded the University of Florida $387,845 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop a personalized sepsis-risk engine using explainable artificial intelligence and in vitro validation. The research integrates multimodal electronic health record data with high-dimensional omics and mechanistic modeling to identify host pathways that convert neutropenic infection into sepsis and...
- The National Institute of General Medical Sciences awarded the University of Wisconsin–Madison $123,309 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop computational methods for improving sepsis diagnosis through plasma metagenomic sequencing. The research addresses the challenge of timely and accurate sepsis diagnosis in critically ill patients by analyzing microbial and host cell-free DNA (cfDNA) in blood plasma. Current diagnostic...
- The National Institute of General Medical Sciences awarded the University of Florida $411,407 on August 15, 2026, to develop a bioanalytical platform for monitoring and modeling sepsis immunopathology under the Biomedical Research and Research Training program (CFDA 93.859). The funded research establishes an integrated platform to capture ultrasensitive, longitudinal biochemical monitoring of immune effectors in sepsis patients and develop dynamic disease models linking biochemical trends to...
- The National Institute of General Medical Sciences awarded Duke University $446,410 on April 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859, R01GM163225) to develop and validate statistical methods for identifying disease subtypes in patient populations, with application to sepsis. The project develops three classes of Bayesian statistical approaches designed to address limitations in standard clustering techniques: Bayesian multiview pyramids to handle...
- The National Institute of General Medical Sciences awarded The Washington University $777,500 on September 19, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate mechanisms driving host-associated microbial community dynamics. The research examines how environmental and host physiological factors interact to shape gut microbial community development and variation across an individual's lifespan, with focus on understanding how normal variation in...
- The National Institute of General Medical Sciences awarded The Washington University $1.244 million on April 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop real-time software-hardware integration for dynamic control of tissue mechanical environments in high-throughput drug development systems. The recipient will integrate four key technologies: rapid algorithms for directly estimating contractility of excitable tissues, GPU-acceleration approaches...
- The National Institute of General Medical Sciences awarded the Regents of the University of Michigan $411,475 under the Biomedical Research and Research Training program (CFDA 93.859) on September 1, 2026, to engineer a multiplexed biomaterial-based bioluminescent biosensor platform for real-time sepsis diagnosis and precision immunotherapy guidance. The recipient will develop a rapid ex vivo biosensor using biomaterial-immobilized complementation antibody pairs to dynamically sense proteomic...
- The National Institute of General Medical Sciences awarded The Washington University $410,520 on April 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research uncovering the molecular principles of intracellular electrochemistry. The recipient will explore fundamental physicochemical and electrochemical features of living systems; establish theoretical frameworks to understand how electrochemical features such as proton motive force define passive...
- The National Institute of General Medical Sciences awarded The Washington University $200,613 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the role of proton-sensing G protein-coupled receptors in trauma and hemorrhagic shock. The research examines how trauma combined with hemorrhagic shock influences expression and activation of proton-sensing G protein-coupled receptors (GPR4 and GPR68) on cerebral endothelial cells, and whether...
- The National Heart, Lung, and Blood Institute awarded Worcester Polytechnic Institute $532,935 on August 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the role of the endothelial glycocalyx in sepsis-induced coagulopathy. The research targets sepsis-associated coagulopathy, a condition characterized by uncontrolled thrombosis, large vessel occlusion, and stroke that resists traditional anticoagulation therapies. The project will examine how sepsis...